These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35772663)
1. Single-cell sequencing reveals the antifibrotic effects of YAP/TAZ in systemic sclerosis. Wu D; Wang W; Li X; Yin B; Ma Y Int J Biochem Cell Biol; 2022 Aug; 149():106257. PubMed ID: 35772663 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis. Toyama T; Looney AP; Baker BM; Stawski L; Haines P; Simms R; Szymaniak AD; Varelas X; Trojanowska M J Invest Dermatol; 2018 Jan; 138(1):78-88. PubMed ID: 28870693 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of yes-associated protein/YAP and transcriptional coactivator with PDZ-binding motif/TAZ activates intestinal fibroblasts to promote intestinal obstruction in Crohn's disease. Ou W; Xu W; Liu F; Guo Y; Huang Z; Feng T; Liu CY; Du P EBioMedicine; 2021 Jul; 69():103452. PubMed ID: 34186485 [TBL] [Abstract][Full Text] [Related]
4. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis. Mooring M; Fowl BH; Lum SZC; Liu Y; Yao K; Softic S; Kirchner R; Bernstein A; Singhi AD; Jay DG; Kahn CR; Camargo FD; Yimlamai D Hepatology; 2020 May; 71(5):1813-1830. PubMed ID: 31505040 [TBL] [Abstract][Full Text] [Related]
5. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501 [TBL] [Abstract][Full Text] [Related]
6. Dapagliflozin delays renal fibrosis in diabetic kidney disease by inhibiting YAP/TAZ activation. Feng L; Chen Y; Li N; Yang X; Zhou L; Li H; Wang T; Xie M; Liu H Life Sci; 2023 Jun; 322():121671. PubMed ID: 37023953 [TBL] [Abstract][Full Text] [Related]
7. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis. Mei X; Zhao H; Huang Y; Tang Y; Shi X; Pu W; Jiang S; Ma Y; Zhang Y; Bai L; Tu W; Zhao Y; Jin L; Wu W; Wang J; Liu Q J Dermatol Sci; 2020 Jul; 99(1):44-52. PubMed ID: 32571632 [TBL] [Abstract][Full Text] [Related]
8. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Mia MM; Cibi DM; Ghani SABA; Singh A; Tee N; Sivakumar V; Bogireddi H; Cook SA; Mao J; Singh MK Cardiovasc Res; 2022 Jun; 118(7):1785-1804. PubMed ID: 34132780 [TBL] [Abstract][Full Text] [Related]
9. Chitturi P; Xu S; Ahmed Abdi B; Nguyen J; Carter DE; Sinha S; Arora R; Biernaskie J; Stratton RJ; Leask A Ann Rheum Dis; 2023 Sep; 82(9):1191-1204. PubMed ID: 37328193 [TBL] [Abstract][Full Text] [Related]
10. Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis. Haak AJ; Kostallari E; Sicard D; Ligresti G; Choi KM; Caporarello N; Jones DL; Tan Q; Meridew J; Diaz Espinosa AM; Aravamudhan A; Maiers JL; Britt RD; Roden AC; Pabelick CM; Prakash YS; Nouraie SM; Li X; Zhang Y; Kass DJ; Lagares D; Tager AM; Varelas X; Shah VH; Tschumperlin DJ Sci Transl Med; 2019 Oct; 11(516):. PubMed ID: 31666402 [TBL] [Abstract][Full Text] [Related]
11. YAP and TAZ regulate skin wound healing. Lee MJ; Byun MR; Furutani-Seiki M; Hong JH; Jung HS J Invest Dermatol; 2014 Feb; 134(2):518-525. PubMed ID: 24108406 [TBL] [Abstract][Full Text] [Related]
12. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
13. YAP/TAZ Signaling in the Pathobiology of Pulmonary Fibrosis. Papavassiliou KA; Sofianidi AA; Spiliopoulos FG; Gogou VA; Gargalionis AN; Papavassiliou AG Cells; 2024 Sep; 13(18):. PubMed ID: 39329703 [TBL] [Abstract][Full Text] [Related]
14. Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling. Wu P; Liu Z; Zhao T; Xia F; Gong L; Zheng Z; Chen Z; Yang T; Duan Q Biochem Biophys Res Commun; 2019 May; 512(4):736-741. PubMed ID: 30926167 [TBL] [Abstract][Full Text] [Related]
15. Involvement of lysophosphatidic acid-LPA Bock-Pereda A; Cruz-Soca M; Gallardo FS; Córdova-Casanova A; Gutierréz-Rojas C; Faundez-Contreras J; Chun J; Casar JC; Brandan E Matrix Biol; 2024 Nov; 133():103-115. PubMed ID: 39153517 [TBL] [Abstract][Full Text] [Related]
16. The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis. Yasuoka H; Yamaguchi Y; Feghali-Bostwick CA PLoS One; 2014; 9(2):e87754. PubMed ID: 24551065 [TBL] [Abstract][Full Text] [Related]
17. The signaling protein Wnt5a promotes TGFβ1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz. Feng Y; Liang Y; Zhu X; Wang M; Gui Y; Lu Q; Gu M; Xue X; Sun X; He W; Yang J; Johnson RL; Dai C J Biol Chem; 2018 Dec; 293(50):19290-19302. PubMed ID: 30333225 [TBL] [Abstract][Full Text] [Related]
18. YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer. Noguchi S; Saito A; Nagase T Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463366 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model. Lee J; Jung Y; Jeong SW; Jeong GH; Moon GT; Kim M Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477764 [TBL] [Abstract][Full Text] [Related]
20. Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis. He X; Tolosa MF; Zhang T; Goru SK; Ulloa Severino L; Misra PS; McEvoy CM; Caldwell L; Szeto SG; Gao F; Chen X; Atin C; Ki V; Vukosa N; Hu C; Zhang J; Yip C; Krizova A; Wrana JL; Yuen DA JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35191398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]